Xeris Biopharma (XERS) shares ended the last trading session 5.6% higher at $5.51. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

In this article, we are going to take a look at where Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) stands against other stocks to invest in for a stock market game. We all have heard the phrase ...

The projected fair value for Xeris Biopharma Holdings is US$6.17 based on 2 Stage Free Cash Flow to Equity Xeris Biopharma Holdings' US$5.03 share price indicates it is trading at similar levels as ...

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2024 Earnings Call Transcript March 6, 2025 Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were ...

NASDAQ XERS opened at $4.24 on Friday. The stock has a market capitalization of $632.10 million, a P/E ratio of -9.42 and a beta of 2.32. Xeris Biopharma has a 52 week low of $1.69 and a 52 week ...

Craig-Hallum raised the firm’s price target on Xeris Biopharma (XERS) to $6.50 from $5 and keeps a Buy rating on the shares following strong Q4 results, and very strong 2025 guidance.